# Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes

> **NCT00435019** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 348 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** insulin detemir
- **DRUG:** insulin NPH
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT00435019
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 348 (ACTUAL)
- **Last updated:** 2017-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00435019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00435019, "Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00435019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*